Next Generation TPD Degraders

Novel protein degradation pathways have the potential to degrade target proteins that the ubiquitin-proteasome system cannot, greatly expanding the applications of TPD in human disease. In this infographic we have taken the opportunity to summarize the TPD next generation degrader landscape, focusing on emerging technologies and developing trends in this novel field.

Next Generation TPD Degraders Infographic

Here are some of the key highlights covered in the infographic:

  • An Overview of the Current Degradation Landscape
  • Emerging Modalities
  • Developing Trends
  • Summary of the Next Generation Degrader Landscape

To learn more about the infographic and how Beacon TPD can enhance your data needs and provide fast insights please book a research session below or contact us directly on beacon@hansonwade.com.

You May Also Be Interested In…

What is Beacon?

Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.

Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.

This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.

We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!

Request Demonstration

Menu
Search Icon
Close Icon
Search